Skip to content

Medical emergency? What to do

Members of Consumer-driven Health Plans Choosing Less Care

3-RXPublished July 8, 20084 min read

Key points

  • Consumer-driven health plans (CDHP) -- hailed since their inception in 2000 as a tool to help control costs -- are resulting in members forgoing care and discontinuing drugs to treat chronic medical problems, according to two newly published studies.
  • "CDHPs seem to influence people because of the higher out-of-pocket costs, but not by making people more informed health-care consumers," Greene said.
  • The medications dropped by consumers are considered asymptomatic, meaning discontinuance doesn't spark a quick return of symptoms.
  • Survey data allowed researchers to focus on enrollee behavior in both high- and low-deductible CDHPs and a preferred provider plan.

Consumer-driven health plans (CDHP) -- hailed since their inception in 2000 as a tool to help control costs -- are resulting in members forgoing care and discontinuing drugs to treat chronic medical problems, according to two newly published studies.

Under employer-offered CDHPs, members pay up-front deductibles either out-of-pocket or from a dedicated health-care account before insurance coverage begins. Proponents -- including President Bush and presumptive Republican presidential nominee John McCain -- argue that consumers in a market-oriented approach will make better health-care choices and drive health-care costs down by doing cost comparisons and accessing information about their conditions. Critics argue that people will instead opt out of important care.

The new research -- published in Health Affairs and led by two University of Oregon policy experts -- offers partial fuel to critics: Many CDHP enrollees were more likely to quit taking drugs that control high blood pressure and cholesterol-lowering medications than were participants with over medical coverage, said Jessica Greene, professor of health policy in the UO's department of planning, public policy and management.

"CDHPs seem to influence people because of the higher out-of-pocket costs, but not by making people more informed health-care consumers," Greene said. "We did not see more use of health information, higher generic drug use or more comparison shopping in terms of diagnostic tests as predicted by proponents. What we did see was that people were two to three times more likely to drop off drugs that treat certain chronic illnesses.

"By cutting back on antihypertensive and lipid-lowering drugs," she added, "there may end up being higher health-care costs in the long run, so these consumers may be making short-sighted, cost-saving decisions that may have higher-cost and unfortunate health ramifications."

The medications dropped by consumers are considered asymptomatic, meaning discontinuance doesn't spark a quick return of symptoms. Researchers also looked at claims involving symptomatic medications for three other chronic conditions -- asthma, depression and ulcers -- but did not see evidence that these drugs were being discontinued at higher rates in the CDHPs.

Greene and Judith Hibbard, a departmental colleague at the UO, were co-authors on both papers in the peer-reviewed journal that explores current health policy issues. The studies separately examined claims data and survey responses of services offered under health-care plans offered to employees of a large Midwest manufacturer.

Survey data allowed researchers to focus on enrollee behavior in both high- and low-deductible CDHPs and a preferred provider plan. They found that enrollees in high-deductible plans were more likely to engage in risky cost-saving behavior by forgoing doctor’s visits to save money. An alarming trend, researchers noted, was that in the second year of the study even some enrollees of a lower-deductible CDHP plan began to postpone or delay medical procedures or to take lower-than-prescribed doses of prescription drugs to save money.

To address these trends, researchers recommend that employers offering CDHPs consider exemptions that would allow employees to get immediate coverage for drugs related to chronic diseases. Uncertainties in federal law regarding which chronic diseases would be allowed under such exemptions need to be revisited by Congress, Greene said.

Researchers also suggest that health-care providers and insurers regularly review claims to pinpoint patients who are forgoing medicine and/or treatment and follow up with alerts to both patients and their physicians about such risky choices.

Co-authors of paper based on prescription claims were Greene and Hibbard of the UO, James F. Murray and Steven M. Teutsch, both of Merck and Company in Westport, Penn., and Marc L. Berger of Eli Lilly and Company in Indianapolis. Anna Dixon, director of policy at the King's Fund in London, was lead and co-author with Greene and Hibbard on the behavioral study.

Both studies were supported by Robert Wood Johnson Foundation's Changes in Health Care Financing and Organization initiative. The study on prescription drug use also received funding from Merck and Company. The Commonwealth Fund provided additional funding for the study on enrollees' behavior.

About the University of Oregon
The University of Oregon is a world-class teaching and research institution and Oregon's flagship public university. The UO is a member of the Association of American Universities (AAU), an organization made up of 62 of the leading public and private research institutions in the United States and Canada. Membership in the AAU is by invitation only. The University of Oregon is one of only two AAU members in the Pacific Northwest.

Source: University of Oregon

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underPublic Health
Public Health

Parasitic DNA proliferates in aging tissues

The genomes of organisms from humans to corn are replete with "parasitic" strands of DNA that, when not suppressed, copy themselves and spread throughout the genome, potentially affecting health. Earlier this year…

4 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.